LeafNLP Demos
Back to explore

Report #2890496

Received Mar 24, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
GA
Recovered
Unknown
Vaccinated
Mar 20, 2026
Onset
Mar 20, 2026
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
MMRMEASLES + MUMPS + RUBELLA (PRIORIX)GLAXOSMITHKLINE BIOLOGICALSUNKSA4C9—
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.UNKZ007581—

Symptoms (2)

Extra dose administeredNo adverse event

Symptom narrative

No additional AE reported. No PQC reported.; Nurse reports she administered both PROQUAD and PRIORIX to an adult male patient today 3/20/2026. No additional AE details provided. Nurse consents to follow-up. No additional AE reported. No PQC reported.; This spontaneous report was received from a nurse and refers to a male patient of unknown age. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications were not reported. On 20-Mar-2026, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), Lot No. Z007581 has been verified to be a valid lot number, expiration date: 12-Oct-2026, administered for prophylaxis (dose, route of administration and anatomical site of injection were not provided). The vaccine was reconstituted with sterile diluent (BAXTER Sterile Diluent), (indication, expiration date, and lot # were not reported). On that same date, the patient was also vaccinated with Measles vaccine live (Schwartz);Mumps vaccine live (RIT 4385);Rubella vaccine live (Wistar RA 27/3)) (PRIORIX) (lot #SA4C9, expiration date: 01-Mar-2027) (overdose). No additional adverse event was reported (no adverse event).

Other medications

DILUENT MRK